1. Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer. (November 2022) Authors: Gough, M.; Kwah, K.; Khan, T.; He, Y.; Pyke, C.; Ratnayake, G.; Snell, C.; Hooper, J.; Kryza, T. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗